封面
市場調查報告書
商品編碼
2153275

2026-2034年全球空間基因組學市場規模、佔有率、趨勢和成長分析報告

Global Spatial Genomics Market Size, Share, Trends & Growth Analysis Report 2026-2034

出版日期: | 出版商: Value Market Research | 英文 254 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

全球太空基因體學市場預計將從2025年的11.6億美元成長至2034年的58.6億美元,2026年至2034年的複合年成長率(CAGR)為19.71%。隨著研究人員尋求揭示細胞和組織內特定位置的基因表現,該市場正在蓬勃發展。空間基因組學技術將基因組分析與空間資訊結合,能夠在保留生物樣本結構的同時研究分子活性。這些技術在癌症研究、發育生物學、神經科學和疾病解析等領域正變得日益重要。對精準醫療和先進分子研究投入的增加正在推動空間分析平台的應用。此外,影像、定序和計算生物學的進步也幫助研究人員更深入地了解細胞間相互作用和組織複雜性。

高解析度生物分析需求的不斷成長、癌症研究計畫的拓展以及闡明細胞層面疾病機制的迫切需求,共同推動了這個市場的成長。研究人員正利用空間基因組學來研究腫瘤微環境、識別細胞間差異並研究不同組織區域的基因活性。單細胞定序、先進的顯微鏡技術以及與生物資訊工具的整合,不斷擴展研究能力。生技公司、製藥公司、學術機構和專業實驗室是主要的終端使用者。然而,設備高成本、數據解讀複雜、樣品製備要求嚴格以及對專業知識的需求,都可能成為推廣應用的障礙。

隨著空間基因組學日益融入生物醫學研究和藥物研發,其市場潛力巨大。定序平台、成像技術、自動化和人工智慧的進步能夠提高分析解析度並降低處理複雜性。製藥公司將能夠利用空間資訊來識別潛在的藥物標靶、研究治療反應並加深對疾病進展的理解。分析平台的便捷獲取和標準化的工作流程有望推動研究機構和臨床開發實驗室的進一步應用。未來的發展將取決於技術的可靠性、數據整合、經濟性和將研究成果轉化為有意義的科學和臨床應用的能力。

我們的報告經過精心撰寫,旨在提供涵蓋廣泛行業和市場的全面且切實可行的洞察。每份報告都包含幾個關鍵組成部分,旨在幫助您全面了解市場環境:

市場概覽:本節對市場進行了清晰的說明,包括關鍵定義、分類以及當前行業格局的概述。

市場動態:對影響市場成長的主要促進因素、限制因素、機會和挑戰進行詳細評估。這包括技術發展、法律規範和不斷變化的行業趨勢等因素。

市場區隔分析:本部分根據產品類型、應用、最終用戶和地區將市場系統性地分類為若干關鍵細分市場。本部分揭示了每個細分市場的表現、成長潛力和市場貢獻。

競爭格局:我們對主要市場參與企業進行了詳細評估,包括其市場定位、產品系列、策略舉措和財務表現。這有助於深入了解競爭趨勢和主要參與者所採取的策略。

市場預測:本部分提供基於數據的市場規模和成長模式預測,預測期為特定時期。它綜合考慮了歷史趨勢、當前市場狀況和定量分析,以識別未來預期趨勢。

區域分析:這包括對主要地理區域的市場表現進行全面檢驗,確定高成長地區和區域趨勢,以更深入地了解區域市場機會。

新趨勢與新機會:識別關鍵市場趨勢、技術進步和新興投資機會。本部分重點在於潛在成長領域和未來產業趨勢。

客製化選項:我們提供靈活的報告客製化服務,以滿足您的特定需求。這包括額外的細分、國家/地區分析、競爭對手分析、客製化資料點或針對特定細分市場的洞察,從而更有效地支援您的策略決策。

目錄

第1章:引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章:全球空間基因體學市場:依產品分類

  • 市場分析、洞察與預測
  • 裝置
  • 耗材和試劑
  • 軟體和數據分析平台
  • 服務

第5章:全球空間基因體學市場:依技術分類

  • 市場分析、洞察與預測
  • 空間轉錄組學
  • 空間蛋白質體學
  • 原位定序
  • 成像質譜流式細胞儀
  • 基於螢光的雜合反應
  • 空間多組體學平台
  • 其他技術

第6章:全球空間基因體學市場:依樣本類型分類

  • 市場分析、洞察與預測
  • 組織樣本
  • 血液樣本
  • 細胞樣本
  • 其他生物樣本

第7章 全球空間基因體學市場:依應用分類

  • 市場分析、洞察與預測
  • 腫瘤學
  • 神經科學
  • 免疫學
  • 發育生物學
  • 心血管疾病
  • 感染疾病
  • 其他用途

第8章:全球空間基因體學市場:依最終用戶分類

  • 市場分析、洞察與預測
  • 製藥和生物技術公司
  • 學術研究機構
  • 醫院/診斷檢查室
  • 受託研究機構
  • 政府附屬研究機構

第9章:全球空間基因體學市場:按地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 中國
    • 日本
    • 韓國
    • 印度
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第10章 競爭格局

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴(根據現有資訊)
  • 市場佔有率和市場定位分析(基於現有資訊)
  • 供應商情況(基於現有資訊)
  • 策略規劃

第11章:公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • 10x Genomics
    • Bruker
    • Illumina
    • Bio-Techne
    • Revvity
    • Thermo Fisher Scientific Inc
    • Danaher Corporation
    • Vizgen
    • Agilent Technologies Inc
    • BGI Genomics Co. Ltd
    • MGI Tech Co. Ltd
    • Carl Zeiss AG
    • Nikon Corporation
    • Resolve Biosciences
    • RareCyte
    • Singleron Biotechnologies Ltd
    • Pixelgen Technologies AB
    • Arima Genomics Inc
    • BioTuring Inc
    • Curio Bioscience
簡介目錄
Product Code: VMR112119847

The global spatial genomics market size is expected to reach USD 5.86 Billion in 2034 from USD 1.16 Billion in 2025, growing at a CAGR of 19.71% during 2026-2034.This market is advancing as researchers seek to understand gene expression within the specific locations of cells and tissues. Spatial genomics technologies combine genomic analysis with spatial information, enabling scientists to examine molecular activity while preserving the organization of biological samples. These methods are increasingly relevant in cancer research, developmental biology, neuroscience, and disease investigation. Growing investment in precision medicine and advanced molecular research is supporting the adoption of spatial analysis platforms. Improvements in imaging, sequencing, and computational biology are also helping researchers obtain more detailed insights into cellular interactions and tissue complexity.

The growth of this market is driven by increasing demand for high-resolution biological analysis, expanding cancer research programs, and the need to understand disease mechanisms at the cellular level. Researchers use spatial genomics to investigate tumor environments, identify cellular differences, and study gene activity across tissue regions. Integration with single-cell sequencing, advanced microscopy, and bioinformatics tools is broadening research capabilities. Biotechnology companies, pharmaceutical developers, academic institutions, and specialized laboratories represent important end users. However, high instrument costs, complex data interpretation, sample preparation requirements, and the need for specialized expertise can limit adoption.

The future prospects of this market are promising as spatial genomics becomes increasingly integrated into biomedical research and drug development. Advances in sequencing platforms, imaging technologies, automation, and artificial intelligence could improve analytical resolution and reduce processing complexity. Pharmaceutical companies may use spatial information to identify potential drug targets, investigate treatment responses, and improve understanding of disease progression. Greater accessibility to analytical platforms and standardized workflows could encourage broader adoption among research institutions and clinical development laboratories. Future expansion will depend on technological reliability, data integration, affordability, and the ability to translate research findings into meaningful scientific and clinical applications.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Product

  • Instruments
  • Consumables And Reagents
  • Software And Data Analysis Platforms
  • Services

By Technology

  • Spatial Transcriptomics
  • Spatial Proteomics
  • In Situ Sequencing
  • Imaging Mass Cytometry
  • Fluorescence In Situ Hybridization
  • Spatial Multiomics Platforms
  • Other Technologies

By Sample Type

  • Tissue Samples
  • Blood Samples
  • Cell Samples
  • Other Biological Samples

By Application

  • Oncology
  • Neuroscience
  • Immunology
  • Developmental Biology
  • Cardiovascular Diseases
  • Infectious Diseases
  • Other Applications

By End User

  • Pharmaceutical And Biotechnology Companies
  • Academic And Research Institutes
  • Hospitals And Diagnostic Laboratories
  • Contract Research Organizations
  • Government Research Organizations

COMPANIES PROFILED

  • 10x Genomics, Bruker, Illumina, Bio-Techne, Revvity, Thermo Fisher Scientific Inc., Danaher Corporation, Vizgen, Agilent Technologies Inc., BGI Genomics Co. Ltd., MGI Tech Co. Ltd., Carl Zeiss AG, Nikon Corporation, Resolve Biosciences, RareCyte, Singleron Biotechnologies Ltd., Pixelgen Technologies AB, Arima Genomics Inc., BioTuring Inc., Curio Bioscience

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL SPATIAL GENOMICS MARKET: BY PRODUCT 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Product
  • 4.2. Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Consumables And Reagents Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Software And Data Analysis Platforms Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.5. Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL SPATIAL GENOMICS MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Technology
  • 5.2. Spatial Transcriptomics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Spatial Proteomics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. In Situ Sequencing Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.5. Imaging Mass Cytometry Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.6. Fluorescence In Situ Hybridization Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.7. Spatial Multiomics Platforms Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.8. Other Technologies Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL SPATIAL GENOMICS MARKET: BY SAMPLE TYPE 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast Sample Type
  • 6.2. Tissue Samples Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Blood Samples Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Cell Samples Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.5. Other Biological Samples Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL SPATIAL GENOMICS MARKET: BY APPLICATION 2022-2034 (USD MN)

  • 7.1. Market Analysis, Insights and Forecast Application
  • 7.2. Oncology Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.3. Neuroscience Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.4. Immunology Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.5. Developmental Biology Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.6. Cardiovascular Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.7. Infectious Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.8. Other Applications Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL SPATIAL GENOMICS MARKET: BY END USER 2022-2034 (USD MN)

  • 8.1. Market Analysis, Insights and Forecast End User
  • 8.2. Pharmaceutical And Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 8.3. Academic And Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 8.4. Hospitals And Diagnostic Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 8.5. Contract Research Organizations Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 8.6. Government Research Organizations Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL SPATIAL GENOMICS MARKET: BY REGION 2022-2034 (USD MN)

  • 9.1. Regional Outlook
  • 9.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.2.1 By Product
    • 9.2.2 By Technology
    • 9.2.3 By Sample Type
    • 9.2.4 By Application
    • 9.2.5 By End User
    • 9.2.6 United States
    • 9.2.7 Canada
    • 9.2.8 Mexico
  • 9.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.3.1 By Product
    • 9.3.2 By Technology
    • 9.3.3 By Sample Type
    • 9.3.4 By Application
    • 9.3.5 By End User
    • 9.3.6 United Kingdom
    • 9.3.7 France
    • 9.3.8 Germany
    • 9.3.9 Italy
    • 9.3.10 Spain
    • 9.3.11 Russia
    • 9.3.12 Rest Of Europe
  • 9.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.4.1 By Product
    • 9.4.2 By Technology
    • 9.4.3 By Sample Type
    • 9.4.4 By Application
    • 9.4.5 By End User
    • 9.4.6 China
    • 9.4.7 Japan
    • 9.4.8 South Korea
    • 9.4.9 India
    • 9.4.10 Australia
    • 9.4.11 South East Asia
    • 9.4.12 Rest Of Asia Pacific
  • 9.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.5.1 By Product
    • 9.5.2 By Technology
    • 9.5.3 By Sample Type
    • 9.5.4 By Application
    • 9.5.5 By End User
    • 9.5.6 Brazil
    • 9.5.7 Argentina
    • 9.5.8 Peru
    • 9.5.9 Chile
    • 9.5.10 Rest of Latin America
  • 9.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.6.1 By Product
    • 9.6.2 By Technology
    • 9.6.3 By Sample Type
    • 9.6.4 By Application
    • 9.6.5 By End User
    • 9.6.6 Saudi Arabia
    • 9.6.7 UAE
    • 9.6.8 Israel
    • 9.6.9 South Africa
    • 9.6.10 Rest of the Middle East And Africa

Chapter 10. COMPETITIVE LANDSCAPE

  • 10.1. Recent Developments
  • 10.2. Company Categorization
  • 10.3. Supply Chain & Channel Partners (based on availability)
  • 10.4. Market Share & Positioning Analysis (based on availability)
  • 10.5. Vendor Landscape (based on availability)
  • 10.6. Strategy Mapping

Chapter 11. COMPANY PROFILES OF GLOBAL SPATIAL GENOMICS INDUSTRY

  • 11.1. Top Companies Market Share Analysis
  • 11.2. Company Profiles
    • 11.2.1 10x Genomics
    • 11.2.2 Bruker
    • 11.2.3 Illumina
    • 11.2.4 Bio-Techne
    • 11.2.5 Revvity
    • 11.2.6 Thermo Fisher Scientific Inc
    • 11.2.7 Danaher Corporation
    • 11.2.8 Vizgen
    • 11.2.9 Agilent Technologies Inc
    • 11.2.10 BGI Genomics Co. Ltd
    • 11.2.11 MGI Tech Co. Ltd
    • 11.2.12 Carl Zeiss AG
    • 11.2.13 Nikon Corporation
    • 11.2.14 Resolve Biosciences
    • 11.2.15 RareCyte
    • 11.2.16 Singleron Biotechnologies Ltd
    • 11.2.17 Pixelgen Technologies AB
    • 11.2.18 Arima Genomics Inc
    • 11.2.19 BioTuring Inc
    • 11.2.20 Curio Bioscience